In an exciting development for the world of genomic medicine, Genomics has successfully raised $35 million in a recent funding round. As a pioneering leader in genomic medicine, Genomics is dedicated to transforming the landscape of clinical trial studies and advancing the practice of personalized medicine. Our expertise encompasses a wide array of applications, including companion diagnostics, assay validation, and cutting-edge practices utilizing next-generation sequencing (NGS), polymerase chain reaction (PCR), and Molecular Anatomic Pathology. This latest infusion of capital is aimed at accelerating our innovative efforts in clinical research and product development, allowing us to optimize our existing platforms and bring forth new diagnostic solutions that empower healthcare providers and improve patient outcomes. With these funds, we plan to enhance our capabilities in high-throughput genomic analyses, expand our partnerships within the healthcare industry, and further our mission to make precision medicine accessible to all. This investment will not only support our ongoing projects but also facilitate exploratory studies that can potentially redefine treatment paradigms in various diseases. As we embark on this next chapter, we are poised to solidify our position as a thought leader in the genomic sector and create a lasting impact on the future of medicine. Genomics is committed to delivering transformative solutions that will shape the way healthcare approaches disease prevention and treatment, and we are grateful for the support of our investors as we work towards these ambitious goals.
Revolutionizing Genomic Medicine: Genomics Secures $35 Million in Funding for Clinical Trial Studies and Diagnostic Advancements
Recently funded 路 拢35.0MBiotechnology Research
Get the full Genomics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
